{"ok":true,"trend":{"id":348625,"platform":"news","region":"global","key":"aptadir has €40m warchest to advance demethylating medicines","title":"Aptadir has €40M warchest to advance demethylating medicines","url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1pQ2szTEVIaWJHNTNjZnRQQ3RXV21YQjVscVpjbk1fWkVuLUJMckVrSDYwbkY2WEw0bTd1UXIyOU12M2lsMjNLM0FPZWlwSnBaQkxr?oc=5","first_seen":"2026-09-29T10:45:55.240876Z","last_seen":"2026-09-29T10:45:55.240876Z","last_rank":37,"peak_rank":37,"last_volume":null,"peak_volume":null,"seen_count":1,"score":8.765,"category_hint":"startups","section":"business","category":"startups","summary":"Spanish biotech Aptadir has secured a €40 million funding package to advance its demethylating medicines, a class of therapies targeting epigenetic changes in cancer cells. The company says the new capital will support development of its pipeline of epigenetic drug candidates as it moves toward clinical progress.","why":"Funding news in the biotech startup space typically draws attention from investors and industry watchers tracking oncology drug development.","tone":"positive","entities":["Aptadir"],"summarized_at":"2026-09-29T10:48:13.240272Z","meta":{"via":"scan","lang":"en","term":"seed round","source":"firstwordpharma.com","published":"Tue, 29 Sep 2026 09:48:17 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Aptadir raises €40M to advance demethylating medicines","section_name":"Business","category_name":"Startups","timeline":[{"captured_at":"2026-09-29T10:45:55.240876Z","rank":37,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1pQ2szTEVIaWJHNTNjZnRQQ3RXV21YQjVscVpjbk1fWkVuLUJMckVrSDYwbkY2WEw0bTd1UXIyOU12M2lsMjNLM0FPZWlwSnBaQkxr?oc=5","author":"firstwordpharma.com","title":"Aptadir has €40M warchest to advance demethylating medicines","snippet":null,"posted_at":"2026-09-29T09:48:17Z","likes":null}],"elsewhere":[],"window":"7d"}}